VALGANCICLOVIR HYDROCHLORIDE

VALGANCICLOVIR HYDROCHLORIDE was reported 19082 times

VALGANCICLOVIR HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 27 0.9000
1 PSEUDOANEURYSM INFECTION 41 0.7736
2 CYTOMEGALOVIRUS SYNDROME 73 0.4424
3 CYTOMEGALOVIRUS NEPHRITIS 19 0.3585
4 ENCEPHALITIS CYTOMEGALOVIRUS 147 0.3356
5 VENA CAVA INJURY 29 0.3152
6 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 93 0.3121
7 IMMUNE RECOVERY UVEITIS 18 0.3103
8 PERINEAL CYST 22 0.3014
9 PERICARDITIS FUNGAL 19 0.2879
10 PYELONEPHRITIS FUNGAL 20 0.2703
11 GRANULOMATOUS ROSACEA 13 0.2653
12 HUMAN EHRLICHIOSIS 49 0.2344
13 CHORIOMENINGITIS LYMPHOCYTIC 16 0.2319
14 CYTOMEGALOVIRUS OESOPHAGITIS 76 0.2065
15 DELAYED GRAFT FUNCTION 141 0.1983
16 VASCULAR PSEUDOANEURYSM RUPTURED 45 0.1940
17 CEREBRAL NOCARDIOSIS 42 0.1803
18 CYTOMEGALOVIRUS VIRAEMIA 770 0.1729
19 RENAL CYST HAEMORRHAGE 37 0.1637
20 CYTOMEGALOVIRUS ENTERITIS 55 0.1545
21 CUTANEOUS NOCARDIOSIS 20 0.1538
22 RETINITIS VIRAL 18 0.1488
23 CUTANEOUS MUCORMYCOSIS 27 0.1467
24 INTRACRANIAL INFECTION 18 0.1440
25 LUNG TRANSPLANT REJECTION 92 0.1394
26 NEW ONSET DIABETES AFTER TRANSPLANTATION 24 0.1387
27 CYTOMEGALOVIRUS GASTRITIS 35 0.1383
28 SMOOTH MUSCLE CELL NEOPLASM 57 0.1364
29 DEAFNESS CONGENITAL 26 0.1294
30 CYTOMEGALOVIRUS GASTROENTERITIS 27 0.1250
31 CYTOMEGALOVIRUS COLITIS 284 0.1234
32 CYTOMEGALOVIRUS INFECTION REACTIVATION 541 0.1223
33 CYTOMEGALOVIRUS CHORIORETINITIS 231 0.1183
34 TRICHOPHYTOSIS 25 0.1179
35 CONGENITAL CYTOMEGALOVIRUS INFECTION 20 0.1176
36 DISSEMINATED CYTOMEGALOVIRAL INFECTION 25 0.1157
37 DRUG RESISTANCE MUTATION 20 0.1124
38 RENAL GRAFT INFECTION 26 0.1121
39 PERINEPHRIC COLLECTION 16 0.1119
40 CYTOMEGALOVIRUS INFECTION 1840 0.1106
41 POLYOMAVIRUS VIRAEMIA 116 0.1092
42 PERIRENAL HAEMATOMA 23 0.1060
43 TERATOGENICITY 32 0.1060
44 PULMONARY NOCARDIOSIS 85 0.1032
45 PANCREAS TRANSPLANT REJECTION 20 0.0995
46 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 221 0.0942
47 CYTOMEGALOVIRUS HEPATITIS 33 0.0932
48 ABDOMINAL WALL HAEMORRHAGE 24 0.0920
49 DONOR SPECIFIC ANTIBODY PRESENT 14 0.0909
50 EPSTEIN-BARR VIRAEMIA 100 0.0902
51 BK VIRUS INFECTION 290 0.0859
52 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 26 0.0858
53 GRAFT LOSS 61 0.0841
54 COMPLICATIONS OF TRANSPLANTED KIDNEY 187 0.0824
55 LYMPHOCELE 54 0.0813
56 CYTOMEGALOVIRUS TEST POSITIVE 144 0.0807
57 TRANSPLANT DYSFUNCTION 144 0.0806
58 TRANSPLANT REJECTION 644 0.0803
59 MONKEYPOX 22 0.0797
60 VASCULAR COMPRESSION 25 0.0791
61 UREAPLASMA INFECTION 32 0.0784
62 GASTROINTESTINAL MUCORMYCOSIS 13 0.0778
63 DERMATOPHYTOSIS 22 0.0775
64 ADENOVIRAL HEPATITIS 18 0.0766
65 RENAL TRANSPLANT FAILURE 74 0.0749
66 MALACOPLAKIA 34 0.0742
67 PNEUMONIA CYTOMEGALOVIRAL 142 0.0730
68 PARVOVIRUS B19 INFECTION 65 0.0726
69 PARVOVIRUS INFECTION 29 0.0718
70 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 13 0.0695
71 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 16 0.0690
72 KIDNEY TRANSPLANT REJECTION 330 0.0687
73 COMPLICATIONS OF TRANSPLANTED LUNG 21 0.0684
74 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 15 0.0679
75 NOCARDIOSIS 173 0.0676
76 PULMONARY MUCORMYCOSIS 34 0.0644
77 SCEDOSPORIUM INFECTION 45 0.0637
78 HEPATIC ARTERY THROMBOSIS 18 0.0614
79 TOXOPLASMOSIS 66 0.0611
80 OESOPHAGEAL ATRESIA 36 0.0576
81 GRAFT THROMBOSIS 15 0.0573
82 RETROPERITONEAL ABSCESS 18 0.0570
83 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 186 0.0563
84 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 16 0.0552
85 PENILE ULCERATION 18 0.0550
86 INFECTION REACTIVATION 62 0.0541
87 MUCORMYCOSIS 139 0.0534
88 GRANULOMATOUS DERMATITIS 13 0.0533
89 FUNGAL ENDOCARDITIS 16 0.0532
90 DISSEMINATED ASPERGILLOSIS 25 0.0530
91 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 19 0.0523
92 EYE INFECTION TOXOPLASMAL 20 0.0504
93 ENTEROCOLITIS VIRAL 15 0.0493
94 GLOMERULOSCLEROSIS 31 0.0491
95 PROTEUS INFECTION 34 0.0474
96 CITROBACTER INFECTION 20 0.0466
97 STRONGYLOIDIASIS 74 0.0458
98 RENAL ARTERY STENOSIS 63 0.0457
99 TRICHODYSPLASIA SPINULOSA 17 0.0446
100 INFECTION IN AN IMMUNOCOMPROMISED HOST 32 0.0446
101 INFECTIVE ANEURYSM 22 0.0444
102 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 70 0.0437
103 BLASTOMYCOSIS 21 0.0432
104 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 214 0.0420
105 CORONA VIRUS INFECTION 18 0.0419
106 PNEUMOCYSTIS JIROVECII INFECTION 50 0.0418
107 EPSTEIN-BARR VIRUS INFECTION 256 0.0409
108 ENTEROVIRUS INFECTION 35 0.0405
109 PATHOGEN RESISTANCE 368 0.0403
110 PERICARDITIS CONSTRICTIVE 17 0.0403
111 MICROSPORIDIA INFECTION 14 0.0399
112 HUMAN HERPESVIRUS 8 INFECTION 24 0.0394
113 CRYPTOCOCCOSIS 64 0.0392
114 ENTEROCOCCAL INFECTION 188 0.0389
115 FUSARIUM INFECTION 27 0.0386
116 HEART TRANSPLANT REJECTION 40 0.0385
117 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 50 0.0380
118 CYTOMEGALOVIRUS ENTEROCOLITIS 29 0.0377
119 CYSTITIS VIRAL 14 0.0366
120 VIRAL HAEMORRHAGIC CYSTITIS 26 0.0365
121 EYE INFECTION FUNGAL 14 0.0362
122 LIVER TRANSPLANT REJECTION 65 0.0362
123 COMPLICATIONS OF TRANSPLANTED LIVER 13 0.0361
124 VIRAEMIA 50 0.0361
125 CERVICITIS 16 0.0359
126 CAROTID ARTERIOSCLEROSIS 37 0.0359
127 HUMAN POLYOMAVIRUS INFECTION 19 0.0358
128 TRANSPLANT FAILURE 86 0.0350
129 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 42 0.0350
130 JC VIRUS INFECTION 55 0.0344
131 BRAIN ABSCESS 85 0.0336
132 INTERVERTEBRAL DISC SPACE NARROWING 27 0.0335
133 ASPERGILLUS INFECTION 220 0.0335
134 TRANSPLANTATION COMPLICATION 14 0.0333
135 DISSEMINATED MUCORMYCOSIS 13 0.0330
136 KLEBSIELLA INFECTION 167 0.0330
137 GASTROENTERITIS ESCHERICHIA COLI 18 0.0329
138 RETINAL SCAR 15 0.0325
139 ADRENAL MASS 27 0.0325
140 PNEUMONIA NECROTISING 21 0.0325
141 TOXIC OPTIC NEUROPATHY 14 0.0323
142 CYSTITIS HAEMORRHAGIC 129 0.0320
143 BACTERIURIA 18 0.0319
144 COMPLICATIONS OF TRANSPLANT SURGERY 16 0.0317
145 ADENOVIRUS INFECTION 91 0.0313
146 OESOPHAGEAL INFECTION 14 0.0313
147 CHRONIC ALLOGRAFT NEPHROPATHY 24 0.0307
148 RECTAL PROLAPSE 37 0.0306
149 STENOTROPHOMONAS INFECTION 41 0.0302
150 ACINETOBACTER INFECTION 33 0.0301
151 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 53 0.0300
152 GRAFT VERSUS HOST DISEASE IN SKIN 66 0.0299
153 NECROTISING RETINITIS 19 0.0297
154 COLON INJURY 17 0.0296
155 RENAL TUBULAR ATROPHY 26 0.0295
156 BRONCHOSTENOSIS 16 0.0293
157 ARTERIAL HAEMORRHAGE 33 0.0289
158 AORTIC DILATATION 32 0.0288
159 CRYPTOSPORIDIOSIS INFECTION 15 0.0286
160 CORYNEBACTERIUM INFECTION 15 0.0280
161 CARDIAC INFECTION 21 0.0280
162 CEREBRAL TOXOPLASMOSIS 26 0.0278
163 KIDNEY FIBROSIS 47 0.0271
164 EPSTEIN-BARR VIRUS TEST POSITIVE 17 0.0269
165 DRUG RESISTANCE 683 0.0266
166 DISSEMINATED CRYPTOCOCCOSIS 20 0.0264
167 BONE MARROW TOXICITY 31 0.0262
168 ACTINIC KERATOSIS 67 0.0258
169 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 27 0.0254
170 CAMPYLOBACTER GASTROENTERITIS 15 0.0253
171 SUPERINFECTION BACTERIAL 20 0.0252
172 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 21 0.0249
173 RENAL TUBULAR INJURY 30 0.0247
174 ENCEPHALITIS VIRAL 30 0.0246
175 VARICELLA ZOSTER VIRUS INFECTION 51 0.0246
176 ANISOCYTOSIS 16 0.0244
177 THROMBOTIC MICROANGIOPATHY 232 0.0238
178 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 50 0.0235
179 HYPERPARATHYROIDISM SECONDARY 58 0.0231
180 NEPHROPATHY TOXIC 259 0.0231
181 URINARY TRACT INFECTION ENTEROCOCCAL 21 0.0225
182 HEPATITIS VIRAL 18 0.0224
183 PNEUMONIA PSEUDOMONAL 34 0.0221
184 GRAFT COMPLICATION 13 0.0221
185 MYCOBACTERIUM AVIUM COMPLEX INFECTION 59 0.0220
186 BRONCHOPULMONARY ASPERGILLOSIS 169 0.0218
187 KLEBSIELLA SEPSIS 24 0.0213
188 CEREBRAL ASPERGILLOSIS 13 0.0211
189 ESCHERICHIA INFECTION 174 0.0211
190 VIRAL LOAD INCREASED 81 0.0208
191 VASOGENIC CEREBRAL OEDEMA 15 0.0208
192 HAEMOLYTIC URAEMIC SYNDROME 48 0.0207
193 PNEUMOCYSTIS JIROVECII PNEUMONIA 207 0.0206
194 RENAL TRANSPLANT 74 0.0205
195 GRAFT VERSUS HOST DISEASE 146 0.0203
196 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 152 0.0202
197 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 28 0.0198
198 ANAL ULCER 16 0.0196
199 BICYTOPENIA 38 0.0194
200 LEUKOPENIA 960 0.0192
201 METAPNEUMOVIRUS INFECTION 15 0.0191
202 PNEUMONIA CRYPTOCOCCAL 18 0.0190
203 PARAINFLUENZAE VIRUS INFECTION 29 0.0190
204 PNEUMONIA FUNGAL 74 0.0187
205 PSEUDOMONAS INFECTION 158 0.0184
206 STREPTOCOCCAL BACTERAEMIA 20 0.0184
207 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 17 0.0184
208 APLASIA PURE RED CELL 61 0.0177
209 MENINGITIS VIRAL 24 0.0175
210 SECONDARY IMMUNODEFICIENCY 21 0.0173
211 ENTEROBACTER INFECTION 29 0.0172
212 ORCHITIS 18 0.0167
213 RENAL TUBULAR NECROSIS 164 0.0167
214 SQUAMOUS CELL CARCINOMA OF SKIN 100 0.0165
215 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 82 0.0164
216 RHINOVIRUS INFECTION 64 0.0164
217 ESCHERICHIA URINARY TRACT INFECTION 69 0.0162
218 PNEUMONIA PNEUMOCOCCAL 24 0.0162
219 HYPERPARATHYROIDISM 33 0.0160
220 OBLITERATIVE BRONCHIOLITIS 21 0.0160
221 AORTIC ARTERIOSCLEROSIS 41 0.0159
222 INTUSSUSCEPTION 15 0.0157
223 LYMPHOPENIA 221 0.0156
224 MEAN CELL VOLUME INCREASED 40 0.0156
225 HEPATOSPLENOMEGALY 40 0.0156
226 SYSTEMIC CANDIDA 39 0.0155
227 GLOMERULONEPHRITIS 38 0.0155
228 PYURIA 15 0.0152
229 GENE MUTATION 30 0.0151
230 ENTEROCOCCAL BACTERAEMIA 16 0.0151
231 HYPOGAMMAGLOBULINAEMIA 98 0.0149
232 CLOSTRIDIUM COLITIS 18 0.0148
233 BACTERIAL SEPSIS 48 0.0147
234 STEROID DIABETES 22 0.0147
235 HYDRONEPHROSIS 108 0.0144
236 NORMOCHROMIC NORMOCYTIC ANAEMIA 43 0.0143
237 HAEMOPHILUS INFECTION 14 0.0143
238 ESCHERICHIA BACTERAEMIA 33 0.0140
239 DISSEMINATED TUBERCULOSIS 36 0.0140
240 NEPHROGENIC DIABETES INSIPIDUS 16 0.0139
241 STAPHYLOCOCCAL SKIN INFECTION 17 0.0138
242 LEFT VENTRICULAR HYPERTROPHY 59 0.0138
243 CYTOPENIA 166 0.0135
244 LUNG TRANSPLANT 48 0.0135
245 ESCHERICHIA SEPSIS 39 0.0134
246 AGRANULOCYTOSIS 247 0.0133
247 LARGE INTESTINAL ULCER 36 0.0132
248 PYELONEPHRITIS ACUTE 26 0.0132
249 HUMAN HERPESVIRUS 6 INFECTION 25 0.0132
250 MENINGITIS CRYPTOCOCCAL 23 0.0131
251 INFECTIOUS PLEURAL EFFUSION 20 0.0131
252 RETROPERITONEAL HAEMATOMA 29 0.0131
253 NEUTROPENIC COLITIS 27 0.0130
254 URINARY TRACT INFECTION BACTERIAL 33 0.0130
255 OESOPHAGEAL CANDIDIASIS 52 0.0130
256 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 36 0.0130
257 PANCYTOPENIA 717 0.0128
258 HEPATIC INFECTION 16 0.0125
259 BRAIN HERNIATION 37 0.0124
260 PYELONEPHRITIS 105 0.0121
261 INTRA-ABDOMINAL HAEMATOMA 15 0.0121
262 LIVER TRANSPLANT 44 0.0121
263 CANDIDA INFECTION 204 0.0121
264 FUNGAEMIA 19 0.0121
265 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 115 0.0120
266 ATYPICAL MYCOBACTERIAL INFECTION 17 0.0120
267 HYPERTENSIVE EMERGENCY 14 0.0119
268 INTERCEPTED MEDICATION ERROR 55 0.0119
269 PNEUMONIA INFLUENZAL 14 0.0118
270 RENAL TUBULAR DISORDER 33 0.0117
271 VIRAL MUTATION IDENTIFIED 43 0.0117
272 HYPERURICAEMIA 46 0.0112
273 CLOSTRIDIUM DIFFICILE COLITIS 117 0.0110
274 MYCOBACTERIAL INFECTION 19 0.0110
275 SEROMA 14 0.0110
276 FUNGAL SKIN INFECTION 44 0.0109
277 ORGANISING PNEUMONIA 54 0.0109
278 ACUTE GRAFT VERSUS HOST DISEASE 49 0.0107
279 BACTERAEMIA 127 0.0107
280 STAPHYLOCOCCAL BACTERAEMIA 46 0.0106
281 HIRSUTISM 14 0.0105
282 RETINITIS 18 0.0104
283 SERUM SICKNESS 29 0.0104
284 GRANULOMA 36 0.0104
285 NOROVIRUS INFECTION 15 0.0104
286 NEUROLOGICAL DECOMPENSATION 24 0.0104
287 INTERCEPTED PRODUCT STORAGE ERROR 37 0.0104
288 PNEUMONIA KLEBSIELLA 19 0.0103
289 BILIARY TRACT DISORDER 14 0.0101
290 NEPHROGENIC ANAEMIA 46 0.0099
291 HERPES SIMPLEX 64 0.0098
292 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 81 0.0098
293 VASCULAR PSEUDOANEURYSM 17 0.0098
294 VENOOCCLUSIVE LIVER DISEASE 48 0.0097
295 SKIN INDURATION 20 0.0096
296 RENAL TUBULAR ACIDOSIS 21 0.0096
297 MULTIPLE-DRUG RESISTANCE 29 0.0093
298 LIVER ABSCESS 30 0.0092
299 HYPERAMMONAEMIA 46 0.0092
300 DIVERTICULUM INTESTINAL 40 0.0091
301 MULTIPLE ORGAN DYSFUNCTION SYNDROME 255 0.0090
302 SPINAL STENOSIS 37 0.0090
303 SEPTIC SHOCK 389 0.0089
304 ANAEMIA MACROCYTIC 19 0.0089
305 ODYNOPHAGIA 53 0.0089
306 HEPATITIS E 14 0.0089
307 CHRONIC GRAFT VERSUS HOST DISEASE 32 0.0089
308 NORMOCYTIC ANAEMIA 13 0.0088
309 NEUTROPENIA 1189 0.0087
310 FIBRIN D DIMER INCREASED 31 0.0087
311 SHOCK HAEMORRHAGIC 71 0.0087
312 BENIGN PROSTATIC HYPERPLASIA 45 0.0087
313 BONE MARROW FAILURE 177 0.0087
314 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 44 0.0087
315 NEPHROGENIC SYSTEMIC FIBROSIS 26 0.0086
316 INFECTED SKIN ULCER 16 0.0085
317 POST PROCEDURAL HAEMATOMA 14 0.0083
318 WOUND DEHISCENCE 28 0.0083
319 GUILLAIN-BARRE SYNDROME 40 0.0083
320 THROMBOCYTOSIS 30 0.0082
321 CALCIPHYLAXIS 15 0.0082
322 NOSOCOMIAL INFECTION 18 0.0082
323 GASTROINTESTINAL ULCER 18 0.0081
324 UROSEPSIS 74 0.0080
325 VENOOCCLUSIVE DISEASE 20 0.0080
326 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 21 0.0079
327 OESOPHAGEAL ULCER 30 0.0078
328 HAEMATOLOGICAL INFECTION 19 0.0078
329 END STAGE RENAL DISEASE 141 0.0077
330 MYELOSUPPRESSION 275 0.0076
331 WOUND COMPLICATION 26 0.0076
332 OLIGURIA 47 0.0076
333 DRUG LEVEL INCREASED 124 0.0075
334 HYPERVOLAEMIA 37 0.0075
335 HEPATIC NECROSIS 28 0.0074
336 DRUG LEVEL ABOVE THERAPEUTIC 34 0.0074
337 RESPIRATORY TRACT INFECTION VIRAL 17 0.0073
338 ABDOMINAL ABSCESS 32 0.0072
339 PSEUDOMEMBRANOUS COLITIS 16 0.0072
340 STAPHYLOCOCCAL SEPSIS 35 0.0071
341 METHAEMOGLOBINAEMIA 16 0.0069
342 PROSTATITIS 21 0.0069
343 LUNG OPACITY 18 0.0068
344 ENDOCARDITIS 35 0.0068
345 CAPILLARY LEAK SYNDROME 14 0.0068
346 OESOPHAGEAL STENOSIS 19 0.0067
347 MIXED LIVER INJURY 20 0.0066
348 HAEMATOTOXICITY 63 0.0066
349 HAEMOLYTIC ANAEMIA 59 0.0066
350 GENERALISED OEDEMA 81 0.0065
351 THROMBOTIC THROMBOCYTOPENIC PURPURA 23 0.0065
352 BLOOD CREATININE INCREASED 425 0.0065
353 INTRAVENTRICULAR HAEMORRHAGE 16 0.0064
354 PNEUMONIA BACTERIAL 59 0.0064
355 URINE OUTPUT DECREASED 56 0.0064
356 SKIN HYPERTROPHY 18 0.0064
357 GASTROINTESTINAL STROMAL TUMOUR 17 0.0064
358 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 14 0.0064
359 HYPOPHOSPHATAEMIA 47 0.0064
360 AORTIC VALVE INCOMPETENCE 27 0.0063
361 VARICELLA 15 0.0063
362 PNEUMONIA VIRAL 20 0.0063
363 CHRONIC GASTRITIS 14 0.0062
364 DUODENITIS 19 0.0062
365 COVID-19 PNEUMONIA 73 0.0062
366 PORTAL HYPERTENSION 19 0.0062
367 TUBULOINTERSTITIAL NEPHRITIS 115 0.0061
368 APLASTIC ANAEMIA 32 0.0061
369 ACUTE RESPIRATORY DISTRESS SYNDROME 108 0.0061
370 CD4 LYMPHOCYTES DECREASED 13 0.0061
371 BACTERIAL INFECTION 113 0.0061
372 BLOOD CULTURE POSITIVE 18 0.0060
373 RENAL IMPAIRMENT 505 0.0060
374 ORAL CANDIDIASIS 79 0.0060
375 CLOSTRIDIUM TEST POSITIVE 13 0.0059
376 IMMUNOSUPPRESSION 52 0.0059
377 PULMONARY TUBERCULOSIS 25 0.0058
378 FIBROSIS 18 0.0058
379 SUBCUTANEOUS ABSCESS 28 0.0058
380 CHOLESTATIC LIVER INJURY 13 0.0058
381 THROMBOCYTOPENIA 640 0.0057
382 BLOOD CREATINE INCREASED 25 0.0056
383 FEBRILE BONE MARROW APLASIA 24 0.0056
384 ACUTE KIDNEY INJURY 862 0.0056
385 CYTOKINE RELEASE SYNDROME 112 0.0056
386 BRAIN OEDEMA 70 0.0055
387 HYPERCALCAEMIA 68 0.0055
388 GASTRIC PERFORATION 15 0.0055
389 HYPERKALAEMIA 191 0.0054
390 RESPIRATORY DISTRESS 148 0.0054
391 HIV INFECTION 16 0.0053
392 STUPOR 17 0.0053
393 PRE-ECLAMPSIA 25 0.0053
394 BLOOD IMMUNOGLOBULIN G DECREASED 13 0.0052
395 LUNG INFILTRATION 46 0.0052
396 FEBRILE NEUTROPENIA 345 0.0052
397 GASTROENTERITIS 75 0.0051
398 ANURIA 44 0.0051
399 STAPHYLOCOCCAL INFECTION 167 0.0051
400 DIFFUSE LARGE B-CELL LYMPHOMA 39 0.0051
401 ENCEPHALITIS 35 0.0051
402 PULMONARY FUNCTION TEST DECREASED 22 0.0050
403 ENTEROCOLITIS 29 0.0050
404 LUNG CONSOLIDATION 14 0.0050
405 HYPERCAPNIA 15 0.0050
406 HEPATITIS CHOLESTATIC 30 0.0050
407 RESPIRATORY FAILURE 363 0.0050
408 HYPOMAGNESAEMIA 69 0.0050
409 LARGE INTESTINE POLYP 34 0.0049
410 NEPHROPATHY 45 0.0048
411 FUNGAL INFECTION 159 0.0048
412 CHOLESTASIS 90 0.0047
413 SPINAL OSTEOARTHRITIS 41 0.0047
414 SEPSIS 520 0.0047
415 COLITIS 175 0.0046
416 BASAL CELL CARCINOMA 72 0.0046
417 ATRIOVENTRICULAR BLOCK FIRST DEGREE 20 0.0046
418 SPLENOMEGALY 54 0.0046
419 METABOLIC ACIDOSIS 147 0.0046
420 ARTERIOSCLEROSIS 43 0.0046
421 OTITIS MEDIA 15 0.0045
422 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 46 0.0045
423 ENCEPHALOPATHY 110 0.0045
424 ACUTE RESPIRATORY FAILURE 86 0.0045
425 HAEMODYNAMIC INSTABILITY 34 0.0045
426 SWELLING OF EYELID 28 0.0045
427 CLOSTRIDIUM DIFFICILE INFECTION 96 0.0044
428 ASCITES 129 0.0044
429 INTENTIONAL PRODUCT USE ISSUE 381 0.0043
430 ATYPICAL PNEUMONIA 13 0.0043
431 MALNUTRITION 47 0.0042
432 GASTROINTESTINAL TOXICITY 20 0.0042
433 ELECTROLYTE IMBALANCE 48 0.0041
434 B-CELL LYMPHOMA 14 0.0041
435 PULSELESS ELECTRICAL ACTIVITY 17 0.0041
436 MYOPATHY 35 0.0040
437 CUSHINGOID 13 0.0040
438 RENAL CYST 32 0.0040
439 ABSCESS LIMB 17 0.0040
440 DYSLIPIDAEMIA 20 0.0039
441 MULTI-ORGAN FAILURE 68 0.0039
442 IMMUNE THROMBOCYTOPENIA 18 0.0039
443 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 15 0.0039
444 PULMONARY ALVEOLAR HAEMORRHAGE 22 0.0039
445 ONYCHOMYCOSIS 17 0.0039
446 HYDROCEPHALUS 21 0.0039
447 CLOSTRIDIAL INFECTION 13 0.0038
448 PROTEINURIA 73 0.0038
449 RETINAL DETACHMENT 35 0.0038
450 FOETAL GROWTH RESTRICTION 23 0.0038
451 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 23 0.0038
452 HEPATOMEGALY 37 0.0038
453 HYPERBILIRUBINAEMIA 39 0.0038
454 CARDIAC DYSFUNCTION 14 0.0038
455 HYPOVOLAEMIA 22 0.0038
456 LEUKOCYTOSIS 68 0.0038
457 APHTHOUS ULCER 29 0.0037
458 HEPATOCELLULAR INJURY 53 0.0037
459 C-REACTIVE PROTEIN INCREASED 136 0.0037
460 BUNDLE BRANCH BLOCK RIGHT 17 0.0037
461 POSTOPERATIVE WOUND INFECTION 25 0.0037
462 GLOMERULAR FILTRATION RATE DECREASED 45 0.0037
463 MENTAL STATUS CHANGES 100 0.0036
464 LARGE INTESTINE PERFORATION 25 0.0036
465 PNEUMOTHORAX 57 0.0036
466 BLOOD POTASSIUM INCREASED 58 0.0036
467 SHOCK 82 0.0036
468 ANAEMIA 677 0.0035
469 OFF LABEL USE 3071 0.0035
470 AZOTAEMIA 14 0.0035
471 PULMONARY MASS 52 0.0035
472 CANDIDIASIS 14 0.0035
473 ORGAN FAILURE 14 0.0035
474 SKIN NECROSIS 18 0.0035
475 BLOOD PRESSURE DIASTOLIC INCREASED 16 0.0035
476 DRUG LEVEL DECREASED 35 0.0034
477 FAECES SOFT 25 0.0034
478 ABSCESS 54 0.0034
479 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 20 0.0034
480 MENINGITIS ASEPTIC 15 0.0033
481 RESPIRATORY SYNCYTIAL VIRUS INFECTION 29 0.0033
482 NEUROLOGICAL SYMPTOM 19 0.0033
483 HEPATITIS 85 0.0033
484 POLYURIA 27 0.0033
485 HYPOXIA 116 0.0033
486 FAILURE TO THRIVE 17 0.0033
487 ACIDOSIS 25 0.0033
488 PLEURAL EFFUSION 198 0.0033
489 HYPERTRIGLYCERIDAEMIA 19 0.0032
490 NECROSIS 18 0.0032
491 INTRACRANIAL PRESSURE INCREASED 18 0.0032
492 DIARRHOEA HAEMORRHAGIC 30 0.0032
493 INCORRECT PRODUCT STORAGE 42 0.0032
494 LEUKAEMIA 30 0.0032
495 FLUID OVERLOAD 46 0.0032
496 GASTRIC ULCER 60 0.0032
497 ORAL DISORDER 23 0.0031
498 HEPATIC CYTOLYSIS 40 0.0031
499 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
500 ATRIOVENTRICULAR BLOCK 24 0.0031
501 HYPOALBUMINAEMIA 24 0.0031
502 DRUG LEVEL BELOW THERAPEUTIC 17 0.0031
503 TONSILLITIS 16 0.0031
504 ADRENAL INSUFFICIENCY 37 0.0030
505 SUBARACHNOID HAEMORRHAGE 31 0.0030
506 VITAMIN D DECREASED 26 0.0030
507 PLEURISY 18 0.0030
508 HYPERNATRAEMIA 15 0.0030
509 HEPATIC LESION 13 0.0030
510 ATELECTASIS 29 0.0030
511 ACUTE HEPATIC FAILURE 41 0.0030
512 MOUTH ULCERATION 63 0.0030
513 FLANK PAIN 28 0.0030
514 HEPATITIS B 18 0.0030
515 HAEMOLYSIS 23 0.0030
516 SKIN TIGHTNESS 14 0.0030
517 VIRAL UPPER RESPIRATORY TRACT INFECTION 14 0.0029
518 WOUND INFECTION 32 0.0029
519 RASH MACULO-PAPULAR 65 0.0029
520 DISSEMINATED INTRAVASCULAR COAGULATION 41 0.0029
521 NEUROTOXICITY 51 0.0029
522 PNEUMONITIS 79 0.0029
523 HEPATIC STEATOSIS 53 0.0028
524 BLOOD LACTATE DEHYDROGENASE INCREASED 45 0.0028
525 ENDOPHTHALMITIS 17 0.0028
526 RENAL FAILURE 376 0.0028
527 ABDOMINAL TENDERNESS 14 0.0028
528 HEPATIC ENZYME ABNORMAL 14 0.0028
529 VIRAL INFECTION 93 0.0028
530 PYREXIA 967 0.0028
531 DRUG INTERACTION 441 0.0028
532 LOW BIRTH WEIGHT BABY 22 0.0028
533 MYOCLONUS 33 0.0028
534 TOXIC EPIDERMAL NECROLYSIS 42 0.0028
535 RALES 16 0.0028
536 LIVER FUNCTION TEST ABNORMAL 80 0.0027
537 ILEUS 34 0.0027
538 CACHEXIA 14 0.0027
539 INFUSION SITE SWELLING 17 0.0027
540 SERUM FERRITIN INCREASED 14 0.0027
541 HYPONATRAEMIA 148 0.0026
542 BLOOD DISORDER 21 0.0026
543 HAEMORRHOIDS 51 0.0026
544 RENAL FAILURE CHRONIC 20 0.0026
545 OSTEOMYELITIS 47 0.0026
546 HAEMOGLOBIN DECREASED 266 0.0026
547 COAGULOPATHY 43 0.0026
548 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 141 0.0026
549 STATUS EPILEPTICUS 29 0.0026
550 HEPATOTOXICITY 57 0.0026
551 HEPATIC FAILURE 77 0.0026
552 NEUTROPHIL COUNT DECREASED 104 0.0025
553 BLOOD MAGNESIUM DECREASED 22 0.0025
554 TERMINAL STATE 17 0.0025
555 PHLEBITIS 13 0.0025
556 GAMMA-GLUTAMYLTRANSFERASE INCREASED 56 0.0025
557 CHRONIC KIDNEY DISEASE 191 0.0025
558 BLOOD PRESSURE FLUCTUATION 60 0.0025
559 HEPATOCELLULAR CARCINOMA 19 0.0025
560 HEPATITIS C 30 0.0025
561 RED BLOOD CELL COUNT DECREASED 71 0.0025
562 HAEMATURIA 85 0.0025
563 RESTLESS LEGS SYNDROME 45 0.0025
564 HAEMORRHAGE INTRACRANIAL 37 0.0025
565 PREMATURE DELIVERY 39 0.0024
566 BLOOD UREA INCREASED 41 0.0024
567 HYPERGLYCAEMIA 89 0.0024
568 CARDIOGENIC SHOCK 35 0.0024
569 SMALL INTESTINAL OBSTRUCTION 30 0.0024
570 FOOD POISONING 13 0.0024
571 TACHYPNOEA 33 0.0024
572 MUCOSAL INFLAMMATION 63 0.0024
573 HEMIPLEGIA 20 0.0024
574 RENAL FAILURE ACUTE 102 0.0024
575 TRICUSPID VALVE INCOMPETENCE 19 0.0024
576 RETINAL HAEMORRHAGE 17 0.0024
577 LYMPHOCYTE COUNT DECREASED 42 0.0024
578 WHITE BLOOD CELL COUNT DECREASED 257 0.0024
579 VISUAL FIELD DEFECT 17 0.0024
580 URINARY TRACT INFECTION 399 0.0023
581 LYMPHOMA 36 0.0023
582 LUNG INFECTION 36 0.0023
583 PRODUCT USE IN UNAPPROVED INDICATION 573 0.0023
584 TRANSAMINASES INCREASED 51 0.0023
585 IMMUNODEFICIENCY 34 0.0023
586 DEVICE RELATED INFECTION 35 0.0023
587 SKIN LESION 62 0.0023
588 LYMPHADENOPATHY 80 0.0023
589 HYPERLIPIDAEMIA 27 0.0023
590 CHOLANGITIS 14 0.0023
591 HEMIPARESIS 38 0.0022
592 BRONCHIECTASIS 15 0.0022
593 BLINDNESS 90 0.0022
594 PNEUMONIA ASPIRATION 55 0.0022
595 SUPRAVENTRICULAR TACHYCARDIA 21 0.0022
596 ENTERITIS 14 0.0022
597 PRESYNCOPE 53 0.0022
598 LUNG DISORDER 106 0.0022
599 HAEMATOMA 56 0.0022
600 TUMOUR LYSIS SYNDROME 19 0.0022
601 AUTOIMMUNE HEPATITIS 15 0.0022
602 HAEMODIALYSIS 18 0.0021
603 HAEMATEMESIS 54 0.0021
604 GASTRITIS 56 0.0021
605 HAEMATOCRIT DECREASED 42 0.0021
606 GENERALISED TONIC-CLONIC SEIZURE 35 0.0021
607 PULMONARY HYPERTENSION 44 0.0021
608 BLOOD IRON DECREASED 25 0.0021
609 ORAL HERPES 41 0.0021
610 MENINGITIS 14 0.0021
611 NEPHROTIC SYNDROME 14 0.0020
612 INFECTION 295 0.0020
613 DYSURIA 75 0.0020
614 LIVE BIRTH 17 0.0020
615 INFUSION SITE ERYTHEMA 17 0.0020
616 ASPIRATION 22 0.0020
617 MYOCARDITIS 23 0.0020
618 FOLLICULITIS 21 0.0020
619 HYPOPHAGIA 51 0.0020
620 PULMONARY OEDEMA 89 0.0020
621 PERICARDIAL EFFUSION 45 0.0019
622 HALLUCINATION, VISUAL 41 0.0019
623 INTERSTITIAL LUNG DISEASE 94 0.0019
624 SKIN ULCER 50 0.0019
625 DIABETES MELLITUS 147 0.0019
626 PNEUMONIA 622 0.0019
627 RESPIRATORY TRACT INFECTION 50 0.0019
628 PULMONARY HAEMORRHAGE 15 0.0019
629 UVEITIS 26 0.0019
630 GENERAL PHYSICAL CONDITION ABNORMAL 13 0.0019
631 SQUAMOUS CELL CARCINOMA 18 0.0019
632 MYOSITIS 17 0.0019
633 CENTRAL NERVOUS SYSTEM LESION 26 0.0019
634 KIDNEY INFECTION 37 0.0019
635 FACIAL PARALYSIS 16 0.0019
636 TOXICITY TO VARIOUS AGENTS 316 0.0019
637 HYPERTRANSAMINASAEMIA 13 0.0019
638 SKIN HYPERPIGMENTATION 16 0.0019
639 MITRAL VALVE INCOMPETENCE 21 0.0019
640 DUODENAL ULCER 13 0.0018
641 NO ADVERSE EVENT 332 0.0018
642 DIVERTICULUM 13 0.0018
643 PULMONARY FIBROSIS 35 0.0018
644 COVID-19 320 0.0018
645 AUTOIMMUNE DISORDER 17 0.0017
646 OEDEMA PERIPHERAL 212 0.0017
647 OESOPHAGITIS 19 0.0017
648 IMPAIRED HEALING 57 0.0017
649 MYELODYSPLASTIC SYNDROME 25 0.0017
650 SCHIZOPHRENIA 21 0.0017
651 PREMATURE BABY 52 0.0017
652 PETECHIAE 18 0.0017
653 ULCER 27 0.0017
654 INTESTINAL PERFORATION 19 0.0017
655 IMPAIRED GASTRIC EMPTYING 23 0.0017
656 PERITONITIS BACTERIAL 17 0.0017
657 OEDEMA 91 0.0017
658 PLATELET COUNT DECREASED 178 0.0017
659 THERAPY NON-RESPONDER 75 0.0017
660 SKIN PLAQUE 14 0.0017
661 CARDIOMEGALY 20 0.0016
662 DIABETIC KETOACIDOSIS 39 0.0016
663 DISEASE RECURRENCE 77 0.0016
664 WHITE BLOOD CELL COUNT INCREASED 62 0.0016
665 RENAL INJURY 48 0.0016
666 HEPATIC FUNCTION ABNORMAL 60 0.0016
667 TREATMENT FAILURE 133 0.0016
668 ATRIAL FIBRILLATION 156 0.0016
669 PERITONITIS 33 0.0016
670 BLOOD COUNT ABNORMAL 24 0.0016
671 GASTROINTESTINAL INFECTION 14 0.0016
672 DRUG-INDUCED LIVER INJURY 49 0.0016
673 DIALYSIS 22 0.0015
674 SINUS TACHYCARDIA 22 0.0015
675 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
676 GLYCOSYLATED HAEMOGLOBIN INCREASED 39 0.0015
677 COLITIS ULCERATIVE 69 0.0015
678 ACUTE MYELOID LEUKAEMIA 24 0.0015
679 DEPRESSED LEVEL OF CONSCIOUSNESS 60 0.0015
680 RENAL DISORDER 70 0.0015
681 BLINDNESS UNILATERAL 21 0.0015
682 CARDIOMYOPATHY 22 0.0015
683 ALANINE AMINOTRANSFERASE INCREASED 91 0.0015
684 CARDIAC ARREST 122 0.0015
685 DIARRHOEA 952 0.0015
686 LIVER INJURY 36 0.0015
687 ACUTE MYOCARDIAL INFARCTION 43 0.0015
688 PRODUCTIVE COUGH 69 0.0014
689 ORTHOSTATIC HYPOTENSION 25 0.0014
690 INFLAMMATION 74 0.0014
691 DYSPNOEA EXERTIONAL 54 0.0014
692 BRADYCARDIA 76 0.0014
693 PERICARDITIS 24 0.0014
694 SKIN INFECTION 16 0.0014
695 DRUG ERUPTION 25 0.0014
696 HERPES ZOSTER 81 0.0014
697 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
698 HYPOTENSION 281 0.0014
699 OSTEONECROSIS 46 0.0014
700 SKIN CANCER 30 0.0014
701 VENTRICULAR TACHYCARDIA 23 0.0014
702 CELLULITIS 70 0.0014
703 ABDOMINAL PAIN 321 0.0014
704 DEEP VEIN THROMBOSIS 89 0.0014
705 UPPER RESPIRATORY TRACT INFECTION 63 0.0014
706 POST PROCEDURAL COMPLICATION 26 0.0014
707 LIVER FUNCTION TEST INCREASED 29 0.0013
708 PRODUCT PRESCRIBING ERROR 32 0.0013
709 TENDERNESS 14 0.0013
710 JOINT RANGE OF MOTION DECREASED 18 0.0013
711 FEAR 36 0.0013
712 THROMBOSIS 107 0.0013
713 DEHYDRATION 177 0.0013
714 HAEMOPTYSIS 37 0.0013
715 URINARY RETENTION 44 0.0013
716 TREMOR 217 0.0013
717 PANCREATITIS ACUTE 29 0.0013
718 GASTROENTERITIS VIRAL 23 0.0013
719 BLOOD SODIUM DECREASED 24 0.0013
720 GASTROINTESTINAL DISORDER 114 0.0013
721 TACHYCARDIA 113 0.0013
722 DELIRIUM 44 0.0013
723 PRODUCT USE ISSUE 238 0.0013
724 ABDOMINAL PAIN LOWER 32 0.0013
725 HELICOBACTER INFECTION 13 0.0013
726 BLOOD BILIRUBIN INCREASED 34 0.0013
727 FISTULA 14 0.0012
728 TREATMENT NONCOMPLIANCE 68 0.0012
729 DIABETES MELLITUS INADEQUATE CONTROL 22 0.0012
730 HYPOKALAEMIA 57 0.0012
731 BODY TEMPERATURE INCREASED 25 0.0012
732 THERAPY PARTIAL RESPONDER 19 0.0012
733 NEOPLASM 14 0.0012
734 HYPERTENSION 255 0.0012
735 EOSINOPHILIA 21 0.0012
736 LIVER DISORDER 53 0.0012
737 PARALYSIS 17 0.0012
738 OSTEOPENIA 18 0.0012
739 TASTE DISORDER 24 0.0012
740 PULMONARY EMBOLISM 112 0.0012
741 CARDIO-RESPIRATORY ARREST 49 0.0012
742 DRUG INEFFECTIVE 1540 0.0012
743 HIATUS HERNIA 15 0.0012
744 FOETAL EXPOSURE DURING PREGNANCY 94 0.0012
745 PHOTOSENSITIVITY REACTION 19 0.0011
746 LACTIC ACIDOSIS 37 0.0011
747 INTERNAL HAEMORRHAGE 13 0.0011
748 RHABDOMYOLYSIS 47 0.0011
749 SUBDURAL HAEMATOMA 16 0.0011
750 CONDITION AGGRAVATED 336 0.0011
751 MUSCULOSKELETAL DISCOMFORT 19 0.0011
752 ANHEDONIA 29 0.0011
753 COMA 52 0.0011
754 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
755 CHOLECYSTITIS 13 0.0011
756 NERVOUS SYSTEM DISORDER 34 0.0011
757 HEPATIC ENZYME INCREASED 73 0.0011
758 GOUT 19 0.0011
759 BRONCHOSPASM 15 0.0011
760 DECREASED APPETITE 244 0.0010
761 FULL BLOOD COUNT DECREASED 21 0.0010
762 DRUG TOXICITY 14 0.0010
763 GASTROINTESTINAL HAEMORRHAGE 85 0.0010
764 MASS 14 0.0010
765 VERTIGO 61 0.0010
766 CHILLS 117 0.0010
767 WEIGHT DECREASED 278 0.0010
768 DEAFNESS 26 0.0010
769 APHASIA 30 0.0010
770 ECONOMIC PROBLEM 15 0.0010
771 LOWER RESPIRATORY TRACT INFECTION 45 0.0010
772 NEURALGIA 24 0.0010
773 RESTLESSNESS 36 0.0010
774 DISEASE PROGRESSION 116 0.0010
775 CONJUNCTIVITIS 18 0.0010
776 COUGH 269 0.0010
777 DYSPHAGIA 91 0.0010
778 HEPATIC CIRRHOSIS 18 0.0010
779 VOMITING 446 0.0009
780 GASTROOESOPHAGEAL REFLUX DISEASE 76 0.0009
781 FLUID RETENTION 48 0.0009
782 HAEMATOCHEZIA 52 0.0009
783 SWELLING FACE 61 0.0009
784 GENERAL PHYSICAL HEALTH DETERIORATION 108 0.0009
785 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 24 0.0009
786 JAUNDICE 25 0.0009
787 CEREBRAL HAEMORRHAGE 33 0.0009
788 PRESCRIBED UNDERDOSE 18 0.0009
789 NIGHT SWEATS 29 0.0009
790 DEATH 762 0.0009
791 CARDIAC FAILURE 70 0.0009
792 MELAENA 19 0.0009
793 CONFUSIONAL STATE 139 0.0009
794 DISORIENTATION 34 0.0009
795 CHOLELITHIASIS 28 0.0009
796 CYSTITIS 27 0.0008
797 DELUSION 13 0.0008
798 RESPIRATORY DISORDER 25 0.0008
799 PANCREATITIS 44 0.0008
800 HAEMORRHAGE 87 0.0008
801 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
802 ASTHENIA 310 0.0008
803 CIRCULATORY COLLAPSE 14 0.0008
804 EXPOSURE DURING PREGNANCY 51 0.0008
805 OXYGEN SATURATION DECREASED 46 0.0008
806 NEUROPATHY PERIPHERAL 77 0.0008
807 PALLOR 22 0.0008
808 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
809 LOCALISED INFECTION 19 0.0008
810 FREQUENT BOWEL MOVEMENTS 21 0.0008
811 CHROMATURIA 17 0.0008
812 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 25 0.0007
813 FAECES DISCOLOURED 16 0.0007
814 CEREBRAL INFARCTION 18 0.0007
815 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
816 LETHARGY 42 0.0007
817 BRONCHITIS 54 0.0007
818 RHINORRHOEA 47 0.0007
819 DRUG INTOLERANCE 70 0.0007
820 PRESCRIBED OVERDOSE 14 0.0007
821 RECTAL HAEMORRHAGE 31 0.0007
822 SKIN DISORDER 24 0.0007
823 ORAL PAIN 16 0.0007
824 RASH PAPULAR 16 0.0007
825 ABDOMINAL DISTENSION 74 0.0007
826 INFLUENZA 79 0.0007
827 RETCHING 15 0.0007
828 DIPLOPIA 18 0.0007
829 HYPOCALCAEMIA 13 0.0007
830 DIVERTICULITIS 19 0.0007
831 PROCEDURAL PAIN 19 0.0007
832 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 20 0.0007
833 OSTEOPOROSIS 28 0.0007
834 SWELLING 63 0.0007
835 NAUSEA 526 0.0007
836 THERAPY CESSATION 34 0.0007
837 MYALGIA 112 0.0007
838 UNRESPONSIVE TO STIMULI 17 0.0007
839 TYPE 2 DIABETES MELLITUS 22 0.0007
840 DYSPNOEA 366 0.0006
841 LABORATORY TEST ABNORMAL 19 0.0006
842 GASTRIC DISORDER 22 0.0006
843 SEIZURE 74 0.0006
844 OROPHARYNGEAL PAIN 59 0.0006
845 STEVENS-JOHNSON SYNDROME 14 0.0006
846 VISUAL IMPAIRMENT 78 0.0006
847 MATERNAL EXPOSURE DURING PREGNANCY 56 0.0006
848 RASH ERYTHEMATOUS 30 0.0006
849 HYPOACUSIS 27 0.0006
850 NEOPLASM MALIGNANT 41 0.0006
851 CONVULSION 35 0.0006
852 PSYCHOTIC DISORDER 18 0.0006
853 OVERDOSE 131 0.0006
854 CEREBROVASCULAR ACCIDENT 102 0.0006
855 HOSPITALISATION 92 0.0006
856 SINUSITIS 61 0.0006
857 HYPOTHYROIDISM 19 0.0006
858 CORONARY ARTERY DISEASE 18 0.0006
859 PLASMA CELL MYELOMA 23 0.0006
860 SKIN DISCOLOURATION 26 0.0006
861 EXTRAPYRAMIDAL DISORDER 14 0.0006
862 ARRHYTHMIA 26 0.0005
863 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 39 0.0005
864 CHEST PAIN 101 0.0005
865 ILLNESS 56 0.0005
866 BLOOD PRESSURE DECREASED 36 0.0005
867 DISCOMFORT 33 0.0005
868 HYPOGLYCAEMIA 26 0.0005
869 RASH PRURITIC 29 0.0005
870 BONE PAIN 31 0.0005
871 CARDIAC FAILURE CONGESTIVE 42 0.0005
872 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
873 ACCIDENTAL OVERDOSE 19 0.0005
874 STOMATITIS 31 0.0005
875 RASH 221 0.0005
876 URINARY INCONTINENCE 15 0.0005
877 HEART RATE INCREASED 50 0.0005
878 CONSTIPATION 110 0.0005
879 INFLUENZA LIKE ILLNESS 41 0.0005
880 MALAISE 217 0.0005
881 NEOPLASM PROGRESSION 17 0.0005
882 ANGINA PECTORIS 14 0.0005
883 ERYTHEMA 100 0.0005
884 DYSGEUSIA 36 0.0005
885 PRODUCT STORAGE ERROR 42 0.0005
886 MUSCULOSKELETAL STIFFNESS 42 0.0005
887 BONE DENSITY DECREASED 15 0.0005
888 FATIGUE 368 0.0005
889 EPISTAXIS 35 0.0005
890 INFUSION RELATED REACTION 31 0.0005
891 HIP FRACTURE 15 0.0005
892 BLOOD POTASSIUM DECREASED 14 0.0005
893 WEIGHT INCREASED 104 0.0005
894 THERAPEUTIC RESPONSE DECREASED 28 0.0005
895 DYSPHONIA 27 0.0005
896 DYSPEPSIA 45 0.0005
897 CATARACT 27 0.0005
898 HEADACHE 284 0.0005
899 BLOOD CHOLESTEROL INCREASED 21 0.0005
900 COGNITIVE DISORDER 21 0.0004
901 AGITATION 33 0.0004
902 PERIPHERAL SWELLING 68 0.0004
903 BLOOD PRESSURE INCREASED 67 0.0004
904 EMOTIONAL DISTRESS 52 0.0004
905 ANXIETY 121 0.0004
906 WHEEZING 25 0.0004
907 LOSS OF CONSCIOUSNESS 54 0.0004
908 HYPOAESTHESIA 63 0.0004
909 JOINT SWELLING 49 0.0004
910 INSOMNIA 108 0.0004
911 RASH MACULAR 14 0.0004
912 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
913 ABDOMINAL DISCOMFORT 67 0.0004
914 DYSARTHRIA 15 0.0004
915 HALLUCINATION 30 0.0004
916 INTESTINAL OBSTRUCTION 15 0.0004
917 UNDERDOSE 29 0.0004
918 PAIN 244 0.0004
919 NASOPHARYNGITIS 73 0.0004
920 ILL-DEFINED DISORDER 24 0.0004
921 NEPHROLITHIASIS 18 0.0004
922 CHEST DISCOMFORT 40 0.0004
923 ANAPHYLACTIC REACTION 21 0.0004
924 MUSCULAR WEAKNESS 43 0.0004
925 MEDICATION ERROR 21 0.0004
926 OSTEOARTHRITIS 16 0.0004
927 PALPITATIONS 44 0.0004
928 CONTUSION 36 0.0004
929 BLISTER 21 0.0004
930 BACK PAIN 86 0.0004
931 INTENTIONAL PRODUCT MISUSE 32 0.0004
932 POLLAKIURIA 15 0.0004
933 DIZZINESS 178 0.0004
934 VISION BLURRED 49 0.0004
935 EYE PAIN 20 0.0004
936 DEPRESSION 80 0.0004
937 FALL 117 0.0004
938 GAIT DISTURBANCE 67 0.0003
939 SYNCOPE 35 0.0003
940 ABDOMINAL PAIN UPPER 72 0.0003
941 EYE SWELLING 13 0.0003
942 ABORTION SPONTANEOUS 14 0.0003
943 MOBILITY DECREASED 25 0.0003
944 MENTAL DISORDER 15 0.0003
945 MUSCULOSKELETAL PAIN 18 0.0003
946 INCORRECT DOSE ADMINISTERED 78 0.0003
947 PRURITUS 131 0.0003
948 NASAL CONGESTION 20 0.0003
949 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
950 ABNORMAL BEHAVIOUR 13 0.0003
951 TINNITUS 15 0.0003
952 PARAESTHESIA 50 0.0003
953 UNEVALUABLE EVENT 24 0.0003
954 CARDIAC DISORDER 29 0.0003
955 FEELING HOT 19 0.0003
956 ARTHRALGIA 122 0.0003
957 MEMORY IMPAIRMENT 40 0.0003
958 NERVOUSNESS 15 0.0003
959 ALOPECIA 56 0.0003
960 SKIN EXFOLIATION 24 0.0003
961 SLEEP DISORDER 20 0.0003
962 BLOOD GLUCOSE INCREASED 53 0.0003
963 HYPERHIDROSIS 36 0.0003
964 PAIN IN EXTREMITY 81 0.0003
965 AMNESIA 17 0.0003
966 BURNING SENSATION 18 0.0003
967 INJURY 18 0.0003
968 BALANCE DISORDER 22 0.0003
969 SUICIDAL IDEATION 23 0.0003
970 SURGERY 14 0.0002
971 SOMNOLENCE 47 0.0002
972 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
973 IRRITABILITY 14 0.0002
974 MYOCARDIAL INFARCTION 40 0.0002
975 ADVERSE EVENT 21 0.0002
976 DRUG DOSE OMISSION 37 0.0002
977 DRY SKIN 29 0.0002
978 ACNE 16 0.0002
979 THERAPY INTERRUPTED 15 0.0002
980 ARTHRITIS 16 0.0002
981 URTICARIA 34 0.0002
982 HYPERSENSITIVITY 37 0.0002
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
984 ADVERSE DRUG REACTION 16 0.0002
985 MUSCLE SPASMS 32 0.0002
986 DRY MOUTH 14 0.0002
987 PRODUCT DOSE OMISSION ISSUE 49 0.0002
988 FLUSHING 16 0.0002
989 PRODUCT QUALITY ISSUE 19 0.0001
990 FEELING ABNORMAL 27 0.0001
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
992 INJECTION SITE PAIN 16 0.0001